Provided by Tiger Trade Technology Pte. Ltd.

Cytokinetics

65.91
+0.27000.41%
Post-market: 66.870.9600+1.46%18:47 EDT
Volume:2.98M
Turnover:196.79M
Market Cap:9.16B
PE:-9.18
High:66.92
Open:65.90
Low:65.25
Close:65.64
52wk High:88.31
52wk Low:53.61
Shares:139.02M
Float Shares:138.02M
Volume Ratio:1.43
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1827
EPS(LYR):-6.5400
ROE:-572.15%
ROA:-28.09%
PB:-52.82
PE(LYR):-10.08

Loading ...

H.C. Wainwright Sticks to Its Buy Rating for Cytokinetics (CYTK)

TIPRANKS
·
Yesterday

Cytokinetics Starts Real-World Study of Myqorzo in Obstructive Hypertrophic Cardiomyopathy

MT Newswires Live
·
Yesterday

Cytokinetics Launches Aspen-HCM: a Real-World Study Evaluating Myqorzo® (Aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy

THOMSON REUTERS
·
Yesterday

Top Executive Makes a Bold Move With Recent Cytokinetics Stock Sale

TIPRANKS
·
Sep 29

Cytokinetics CEO Robert I. Blum Disposes of USD 490,950 in Common Shares

Reuters
·
Sep 29

Aspen Aerogels, Sezzle, PIMCO, Kimbell, Cytokinetics Insider Moves

TIPRANKS
·
Sep 26

Top Cytokinetics Executive Makes Notable Stock Move in High-Value Sale

TIPRANKS
·
Sep 23

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of Common Shares Worth $239,015

Reuters
·
Sep 23

Cytokinetics Grants 52,834 Inducement Stock Options at USD 69.31 Strike Price

Reuters
·
Sep 18

Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 18

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 18

Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program

THOMSON REUTERS
·
Sep 14

Cytokinetics Insider Move Sparks Fresh Investor Buzz

TIPRANKS
·
Sep 12

Cytokinetics Director Robert E. Landry Sells 1,000 Common Shares Worth $74,660

Reuters
·
Sep 12

Cytokinetics Has Advantage in Bristol-Myers Squibb Patent Dispute, RBC Says

MT Newswires Live
·
Sep 11

Cytokinetics EVP R&D Malik Fady Ibraham Disposes of 3,500 Common Shares for $264,110

Reuters
·
Sep 09

Movement Alert|Cytokinetics Rises 5.1% in Regular Trading, ESC Congress Data and Label Expansion Plans Continue to Boost Sentiment

Market Focus
·
Sep 09

Cytokinetics Management to Join Citi BioPharma Investor Conference Fireside Chat

Reuters
·
Sep 03

High-Profile Insider Move Shakes Up Cytokinetics Watchers

TIPRANKS
·
Sep 02

Cytokinetics CEO Robert I. Blum Disposes of $526,800 in Common Shares

Reuters
·
Sep 01